NIH

Vanderbilt investigators are invited to submit pre-proposals for the 2026 NIH S10 Shared and High-End Instrumentation Grant programs, which support the purchase of state-of-the-art shared research equipment for NIH-funded research. Pre-proposals are required for institutional review and approval before submission to the NIH, with a university deadline of April 1 ahead of the NIH’s June 1 deadline. Read More

The announcement of the recognition of VMAC as an NIH Center of Excellence comes nearly five years after the creation of an exploratory NIA-funded Alzheimer’s Disease Research Center. Read More

Kevin Murphy, Andrew W. Mellon Chair in the Humanities and professor of history of art and architecture, and Mary Anne Hunting, BA’80, have uncovered the histories of female architects in the American Modernism period of the U.S. in new research. Read More

A recent study by Paula Luis and Claus Schneider, researchers in the Vanderbilt University School of Medicine Basic Sciences Department of Pharmacology and the Vanderbilt Institute of Chemical Biology, has uncovered substantial inconsistencies in the alkaloid content of Corydalis yanhusuo dietary supplements. Read More

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. Read More

Submissions are open for pre-proposals for the 2025 National Institutes of Health S10 Shared and High-End Instrumentation Grant programs, which fund state-of-the-art shared research equipment. Internal pre-proposals are due by April 1, 2025, to allow institutional review before the June 2 NIH deadline, with guidance available from OVPRI and VBS. Read More

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

In 2024 the National Institutes of Health awarded Sando a New Innovator Award, part of their High-Risk, High-Reward Research program. This award, which provides $1,500,000 over five years, supports early-career scientists proposing innovative and impactful research that might not get funded in the traditional peer-review process due to its inherent risk. Read More

Krish Roy, Bruce and Bridgitt Evans Dean of the School of Engineering, recently engaged in a leadership roundtable in Washington, D.C. with NIH Director Dr. Monica M. Bertagnolli. Hosted by United for Medical Research (UMR), the forum addressed critical issues in biomedical research funding and efforts to secure sustained federal investments in this vital area. Read More

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years. Read More